Big Data & Research - Acquisition, Analytics, and Exploitation
May 2019. Claims of doing “research”, in particular to pursue “scientific” interests are regularly invoked when it comes to be exempted from common regulations or claim privileges. This is particularly evident, if acquiring, analysing, or exploiting “Big Data”. While proven scientific pursuits rightly enjoy public privileges, blanket attributions of doing nothing else but “science”, inflationary exploit of research privileges, or dubious roles of “scientists” have been raising widespread public concerns.
Ulrich Gassner, Professor of Public Law at Universität Augsburg (DE) offers a legal perspective from current debates in German and EU regulations following GDPR in 2018. How is oversight organised in the EU? What about moving health data acroos borders? With examples from DigiMed, a Big Data healthcare project by the Bavarian Government.Reading time: 13 min
Read Now: |
Other articles recommended
B2Bioworld offers you background information
GAIA-X: Thorny Path to Live Up to High Hopes
Analysis and in-depth interview with GAIA-X aisbl executives
“We have some of the biggest databases in the world…”
Health Apps for YEPPs – Forget about regulations?
Regulatory Challenges of Big Data Operations – Algorithms, Healthcare, or Autonomous Driving
Patenting and Innovation in Japan
Prof Sadao Nagaoka, Institute of Innovation Research, and Chief Policy Adviser to the Japanese Government